Sources monitored: 100
← Back to signals
MediumRegulatory· Food & Feed Safety RegulationSIG-2026-ED2FL4

UK Food Standards Agency Proposes Revocation of Ethoxyquin Feed Additive Authorisation

The Food Standards Agency (FSA) and Food Standards Scotland (FSS) launched a consultation on the proposed revocation of the authorisation for ethoxyquin as a feed additive. This move follows a lack of required data from industry proponents to address safety concerns regarding the substance's impact on animal and environmental health, effectively moving toward a permanent ban.

StrongEscalatingNear-termProcurement

Telemetry is advisory — directional context, not a deterministic risk score.

2026-07-14UK#food-safety#animal-feed#fsa-regulation#supply-chain-risk#chemical-compliance

Strategic Governance Impact

Structural governance significance — not general importance.

22 / 100

Operational information

The UK Food Standards Agency is proposing to revoke the authorization of a specific animal feed additive due to safety data gaps. This is a routine, product-specific regulatory adjustment that requires standard supply chain compliance from affected businesses. It does not introduce new governance frameworks, alter executive accountability, or redefine risk assurance methodologies.

Exposure pathway

Manufacturers, importers, and retailers of animal feed and livestock products are directly exposed to supply chain disruption and compliance risk. Procurement teams must identify the presence of ethoxyquin in current formulations to prevent non-compliance upon the 2026 revocation date.

What may need to be proven

Operators will be required to provide updated product specifications and supply chain certificates ensuring that feed additives do not contain ethoxyquin. Compliance audits will require explicit testing or declarations from upstream chemical suppliers.

Operational consequence mapping

What this signal actually changes

What operational condition changed?
A previously permitted feed additive (ethoxyquin) is moving from a suspended status to a permanent revocation of lawful use.

Consequence analysis · premium

Full operational consequence mapping — actors exposed, broken assumptions, evidence expectations, operational burden — is reserved for Premium and Executive subscribers.

Request access

Source citation

UK GOV.UK Policy Papers

GRandCIndex monitors source publications without reproducing them verbatim. Original materials remain the authoritative reference.

Executive interpretation · premium

Premium subscribers receive structured interpretation: cross-jurisdictional read-across, board-level translation, and proof-exposure mapping linked to internal control taxonomy.

Request access

Convergent signals

Reinforcing pressure across different stories

  • High
    2026-08-25US#ics-security#transportation-safety#vulnerability-management#cisa-advisory
    SIG-2026-U8RTT9
    StrongEscalatingImmediateEngineering

    CISA Issues Critical Advisory on Bendix EC80 Brake ECU Vulnerabilities Impacting Transportation Systems

    The Cybersecurity and Infrastructure Security Agency (CISA) released an Industrial Control Systems (ICS) advisory detailing high-severity vulnerabilities in Bendix EC80 Brake Electronic Control Units (ECUs). These flaws, including stack-based buffer overflows and hard-coded credentials, could allow attackers to remotely execute code or inject CAN bus traffic, potentially disabling critical vehicle functions such as ABS, steering assist, and traction control. This advisory highlights structural risks to fleet operations and transportation safety across North America.

+5 more reinforcing signals · premium

Unlock

Pattern context

Related signals in the same risk surface

  • Medium
    2026-08-25US#fda-authorization#medical-devices#digital-health#wearable-tech
    SIG-2026-1HWYI5
    StrongEscalatingImmediateEngineering

    FDA Authorizes First Wearable Dual Glucose and Ketone Continuous Monitoring System

    The U.S. Food and Drug Administration (FDA) authorized the marketing of the Libre Duo 10 Day Continuous Dual Glucose-Ketone Monitoring System, the first wearable device capable of simultaneous, continuous tracking of both metrics. This de novo authorization establishes a new regulatory precedent for integrated metabolic monitoring devices intended for individuals aged two and older with diabetes.

+3 more related signals · premium

Unlock